Please select the option that best describes you:
Topics:
Internal Medicine • COVID-19 • Infectious Disease • Pulmonology • General Infectious Disease
What is your approach to the use of Paxlovid for patients with risk factors for severe Covid-19 infection but who have received SARS-CoV-2 vaccines in light of the EPIC-SR trial findings?
Answer from: at Community Practice
Although EPIC-SR Trial may not have shown a significant benefit of paxlovid in standard-risk patients regardless of vaccination status, EPIC HR and real-world evidence have shown benefits in high-risk populations. Shared decision-making with the patient is always the best policy.Disclosure: I have r...
Sign in or Register to read more
Answer from: at Community Practice
Hopefully, the question is moot. Two days ago, I asked my team when the last time we had a patient who even tested COVID+. I couldn't remember any. We may have had 1 patient, who tested COVID+ in the last 3 months. We haven't had a patient, who was ill from COVID, in a year or so. An interesting dev...